Post by
gojotv! on Dec 11, 2021 2:33am
Don't forget "Right to Try"
Here's what I expect.
We get BTD within 6 months. Then, solid data starts coming in revealing TLT's treatment to be the best and easiest to administer and tolerate... by far.
Then, "Right to Try-ers" start asking for the treatment.
Yes, before Ph2 is complete...
They get the treatment at their local urology clinic - money is no object for these early adopters.
So... no further PP's... Minimal dilution because of warrants... Solid finances.
And that's not counting Covid.
Sound unreasonably optimistic?
Don't underestimate the will of a person who's facing losing their bladder.
Comment by
Oilminerdeluxe on Dec 11, 2021 4:11am
Sounds fine to me. I have a feeling Theralase will be half my portfolio come late February. Probably not wise, but I have never claimed to be wise. The recent Sherri talks was interesting. She is busy. But man would Ilike to hear them start talking about GBM. Patience is learned the hard way, I guess. An interesting 2022 to say the least.